Valion Bio, Inc. business relationships
Companies named in Valion Bio, Inc.’s 10-K filed 2026-03-30, and public companies whose annual reports name Valion Bio, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 3.6 / 10
- AI naming
- <1 / 100 Top 55% in its category
- Agent readiness
- 5 / 100
- AI adoption
- 0 / 100
Named in Valion Bio, Inc.’s annual report 1
“A cornerstone of this transition was the execution of an exclusive worldwide licensing agreement with Statera Biopharma, Inc. This agreement added Entolimod™, a late-stage Toll-like Receptor 5 (TLR5) agonist, to our clinical pipeline.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.